UNSPSC 51152074: Tubocurarine chloride

This classification denotes a muscle relaxant, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 900961Z8VR. European Medicines Agency schedules Curare in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB49132. Tubocurarine chloride generally arises in the molecular formula C37H41N2O6.CL.CLH.5H2O. The term 'tubocurarine chloride' is a United States Homeopathic Pharmacopoeia Name designation. Most nations, for tariff and trade purposes, schedule tubocurarine chloride under HS 29399900 and SITC 54149.

As of Q4 2014, TUBOCURARINE CHLORIDE remains US FDA's Preferred Term for this commodity. Tubocurarine chloride bears US NLM identifiers UMLS ID C0282372 and NCI Concept Code C47777. SMILES: CN1CCC2CC(C3CC2[C@@H]1CC4CCC(CC4)OC5C6C(CC(C5O)OC)CC[N+]([C@@H]6CC7CCC(C(C7)O3)O)(C)C)OC.O.O.O.O.O.CL.[CL-].

UNSPSC 51152074 Tubocurarine chloride is a Commodity code that reflects pharmaceuticals and active pharmaceutical ingredients procured by state and local health agencies, though recent activity under this specific code shows minimal direct alignment with its nominal scope. The two posted opportunities tagged to this code involve naloxone procurement (an opioid antagonist used in overdose reversal) and a market-intelligence inquiry into direct-to-manufacturer prescription programs by a state health commission — neither of which is tubocurarine chloride. The issuing bodies represent different procurement modalities: Seminole County, Florida, a county health authority, used a competitive bid (IFB) for consumable pharmaceuticals supporting community health, while the Texas Health and Human Services Commission issued a Request for Information to gather vendor capabilities on prescription-fulfillment models rather than to source a specific drug product. This mismatch suggests either that state and local procurement offices are tagging diverse pharmaceutical and pharmacy-related acquisitions under a single commodity code, or that the code itself is not in active use for its titular substance.

Geographic activity in the source spans Florida and Texas, representing county-level and state-level health procurement. Seminole County's naloxone IFB (Solicitation IFB60459723LAS, response due July 26, 2023) called for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, fixed-fee pricing, and a two-year initial term with one-year renewal option; the Texas HHS RFI (HHS0017013, posted April 3, 2026) was exploratory, seeking vendor information on direct manufacturer relationships for pharmacy benefit programs without a formal award or budget identified. No standout repeat buyers appear in the recent record, and no other states show activity under this code. The sparse and divergent nature of recent opportunities suggests limited current pursuit value under this specific UNSPSC code for tubocurarine chloride itself.